yearly return for cctra stock 2011-2019

GT Biopharma (GTBP) had the best year between 2011 and 2019 by a US stock in 2012, returning 3,044,698,370%.

ASSET YEAR % RETURN
Versus Systems Inc. (VS)
2011
1,473%
InnovAge (INNV)
2011
2,566.67%
Sequans Communications (SQNS)
2011
3,349,297.59%
Castellum (CTM)
2011
6,521,639.13%
Nova Lifestyle I (NVFY)
2011
2,733.33%
GT Biopharma (GTBP)
2012
3,044,698,370%
QXO (QXO)
2012
1,151,950%
Intellinetics (INLX)
2012
8,066.67%
Actinium Pharmaceuticals (ATNM)
2012
1,400%
Par Pacific (PARR)
2012
1,900%
Vivakor (VIVK)
2013
1,126.43%
NextTrip (NTRP)
2013
1,175.86%
Nutex Health (NUTX)
2013
749,900.2%
DarioHealth (DRIO)
2013
1,250%
Almonty Industries Inc Common Shares (ALM)
2013
849.8%
Andretti Acquisition Corp II Class A Ordinary Shares (POLE)
2014
896.73%
PCB Bancorp (PCB)
2014
527,363,000%
Ainos (AIMD)
2014
2,057.89%
PetVivo (PETV)
2014
64,689.33%
Inventrust Properties (IVT)
2014
1,067,615%
GT Biopharma (GTBP)
2015
9,042.86%
Eastside Distilling (BLNE)
2015
7,995.95%
FiEE (FIEE)
2015
1,340.99%
SurgePays (SURG)
2015
4,400%
GreenPro Capital (GRNQ)
2015
1,400%